| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |